Open Beta
TREN
MetriLume
TREN

US marketsZBIO

SEC-sourced researchBeta

ZBIO

Zenas BioPharma, Inc.

Company comparison ↗

Data passport

CIK
0001953926
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 5,000,000.0000 USD; December 2025: 10,000,000.0000 USD10M USD0 USD0December 2024December 2025
ZBIO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20245,000,000.0000Mar 16, 2026
December 202510,000,000.0000Mar 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202510,000,000.0000-377,737,000.0000-172,333,000.0000383,640,000.0000141,496,000.0000Mar 16, 2026
December 20245,000,000.0000-156,988,000.0000-119,674,000.0000369,968,000.000057,510,000.0000Mar 16, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$10MDecember 2025Mar 16, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$5MDecember 2024Mar 16, 202610-K
Net incomeNetIncomeLoss-$377.74MDecember 2025Mar 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$172.33MDecember 2025Mar 16, 202610-K
Total assetsAssets$383.64MDecember 2025Mar 16, 202610-K
Total liabilitiesLiabilities$141.5MDecember 2025Mar 16, 202610-K

New filings

Explore methodology ↗